ARTICLE | Company News
Lorus, Brock University deal
December 24, 2012 8:00 AM UTC
Lorus partnered with the university to develop cancer drugs based on chemical derivatives of pancratistatin, a natural compound. Lorus will be responsible for testing the anticancer activity and drug-...